Pdt Partners, LLC Agios Pharmaceuticals, Inc. Transaction History

Pdt Partners, LLC

$1.01 Billion
Q1 2024

A detailed history of Pdt Partners, LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 93,404 shares of AGIO stock, worth $4.03 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

93,404

Previous 85,153 9.69%

Holding current value

$4.03 Million

Previous $1.9 Million 44.04%

% of portfolio

0.27%

Previous 0.22%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$21.32 - $34.81 $175,911 - $287,217	8,251 Added 9.69%	93,404 $2.73 Million
Q4 2023 Feb 14, 2024	BUY	$19.97 - $24.53 $777,851 - $955,468	38,951 Added 84.31%	85,153 $1.9 Million
Q3 2023 Nov 14, 2023	BUY	$24.36 - $28.18 $68,013 - $78,678	2,792 Added 6.43%	46,202 $1.14 Million
Q2 2023 Aug 14, 2023	BUY	$21.38 - $29.19 $367,586 - $501,863	17,193 Added 65.58%	43,410 $1.23 Million
Q1 2023 May 15, 2023	SELL	$21.74 - $30.93 $813,249 - $1.16 Million	-37,408 Reduced 58.79%	26,217 $602,000

Q4 2022 Feb 14, 2023	SELL	$24.81 - $31.52 $227,085 - $288,502	-9,153 Reduced 12.58%	63,625 $1.79 Million
Q3 2022 Nov 14, 2022	SELL	$19.51 - $34.14 $853,640 - $1.49 Million	-43,754 Reduced 37.55%	72,778 $2.06 Million
Q2 2022 Aug 15, 2022	BUY	$17.06 - $31.42 $1.44 Million - $2.65 Million	84,258 Added 261.07%	116,532 $2.58 Million
Q1 2022 May 16, 2022	BUY	$26.68 - $34.81 $861,070 - $1.12 Million	32,274 New	32,274 $939,000
Q2 2021 Aug 16, 2021	SELL	$52.06 - $61.27 $3.73 Million - $4.39 Million	-71,700 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$44.23 - $57.5 $1.81 Million - $2.35 Million	-40,878 Reduced 36.31%	71,700 $3.7 Million
Q4 2020 Feb 16, 2021	BUY	$33.21 - $46.54 $208,492 - $292,178	6,278 Added 5.91%	112,578 $4.88 Million
Q3 2020 Nov 16, 2020	BUY	$33.87 - $55.93 $992,390 - $1.64 Million	29,300 Added 38.05%	106,300 $3.72 Million
Q2 2020 Aug 14, 2020	SELL	$34.45 - $53.48 $531,701 - $825,410	-15,434 Reduced 16.7%	77,000 $4.12 Million
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $91,344 - $155,941	-2,898 Reduced 3.04%	92,434 $3.28 Million
Q4 2019 Feb 14, 2020	BUY	$30.08 - $50.59 $668,738 - $1.12 Million	22,232 Added 30.41%	95,332 $4.55 Million
Q3 2019 Nov 14, 2019	SELL	$32.4 - $49.58 $680 - $1,041	-21 Reduced 0.03%	73,100 $2.37 Million
Q2 2019 Aug 14, 2019	BUY	$46.17 - $68.1 $3.38 Million - $4.98 Million	73,121 New	73,121 $3.65 Million
Q3 2018 Nov 14, 2018	SELL	$71.67 - $91.95 $4.74 Million - $6.09 Million	-66,200 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$73.22 - $99.55 $3.21 Million - $4.36 Million	-43,836 Reduced 39.84%	66,200 $5.58 Million
Q1 2018 May 15, 2018	SELL	$59.83 - $86.53 $2.47 Million - $3.57 Million	-41,232 Reduced 27.26%	110,036 $9 Million
Q4 2017 Feb 14, 2018	SELL	$52.12 - $72.33 $1.82 Million - $2.52 Million	-34,833 Reduced 18.72%	151,268 $8.65 Million
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $10.2 Million - $12.5 Million	186,101	186,101 $12.4 Million

Others Institutions Holding AGIO

# of Institutions

207

Shares Held

60M

Call Options Held

365K

Put Options Held

457K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.36B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account